drugset / Trial / NCT03865563

Selective Transvenous Chemoembolization of Primary Pancreatic Tumors

NCT03865563

NaSingle-groupOpen-labelTreatment

Summary

Catheter directed retrograde venous infusion of gemcitabine/lipiodol into pancreatic tumors.

Timeline

Start
2019-07
Primary completion
2021-06
Completion
2021-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Gemcitabine Small molecule Other
Background lipiodol Unknown Other